Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Main Author: | Forbes, E |
---|---|
Other Authors: | Hill, A |
Format: | Thesis |
Language: | English |
Published: |
2011
|
Subjects: |
Similar Items
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
by: Kapulu, MC
Published: (2014) -
Developing novel blood-stage malaria vaccines
by: Douglas, AD
Published: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
by: Bauza, K
Published: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
by: de Cassan, S
Published: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
by: Elias, SC
Published: (2014)